Controversial NIH Director Also Takes Helm at CDC Amid RFK Jr.
Jay Bhattacharya, the controversial NIH Director, has been appointed acting CDC Director, marking an unusual dual role amidst Health Secretary Robert F. Kennedy Jr.'s leadership shake-up. Critics express alarm over Bhattacharya's perceived lack of leadership and history of endorsing anti-vaccine policies, fearing further destabilization of public health agencies and a rubber-stamping of unscientific agendas.
Controversial NIH Director Also Takes Helm at CDC Amid RFK Jr. Shake-Up
Key takeaways
- Jay Bhattacharya, the current Director of the National Institutes of Health (NIH), has been appointed acting Director of the Centers for Disease Control and Prevention (CDC).
- This unusual dual role occurs amidst significant leadership changes within the Department of Health and Human Services (HHS) under anti-vaccine Secretary Robert F. Kennedy Jr.
- Bhattacharya's leadership at NIH has been criticized for defunding research, numerous vacancies, and a perceived hands-off management style.
- Public health experts express concern that he will continue to rubber-stamp Kennedy's anti-vaccine agenda, as he previously approved drastic cuts to childhood vaccine recommendations.
- His tenure as acting CDC director is temporary, legally limited to 210 days, with a deadline for a permanent nomination approaching on March 25.
What happened
Jay Bhattacharya, currently serving as the Director of the National Institutes of Health (NIH), has additionally assumed the role of acting Director for the Centers for Disease Control and Prevention (CDC). This is an uncommon arrangement that has immediately drawn sharp criticism from scientific researchers and public health experts. The appointment is part of a broader leadership restructuring within the Department of Health and Human Services (HHS), spearheaded by anti-vaccine Health Secretary Robert F. Kennedy Jr. Bhattacharya is the third leader for the CDC under Secretary Kennedy's administration, highlighting a period of significant turnover for the public health agency.
Why it matters
This dual appointment is highly significant due to the ongoing turmoil within US public health agencies and Bhattacharya's controversial record at the NIH. Critics argue that his perceived lack of hands-on leadership at NIH, which has seen hundreds of millions of dollars in research grants frozen or terminated and an unprecedented number of vacancies, makes him ill-suited to oversee two vital institutions simultaneously. The appointment raises concerns about the stability and scientific independence of both the NIH and CDC. Experts fear that Bhattacharya will further facilitate Secretary Kennedy's anti-vaccine agenda, potentially undermining evidence-based public health practices and contributing to the resurgence of preventable diseases, such as measles.
Key details / context
The CDC has experienced considerable instability under Secretary Kennedy's leadership. Susan Monarez, a microbiologist and the first Senate-confirmed CDC director under Kennedy, was ousted within a month for allegedly refusing to endorse changes to vaccine recommendations proposed by Kennedy's anti-vaccine advisors. Her successor, Jim O'Neill, a Silicon Valley investor and ally of Peter Thiel, then served as acting director and approved a dramatic overhaul of the CDC's childhood vaccine recommendations. O'Neill is reportedly now slated for nomination to lead the National Science Foundation.
While Bhattacharya, a health economist with a medical degree, possesses more relevant qualifications than O'Neill, his leadership at NIH has been contentious. A recent Senate report revealed that under his directorship, the NIH halted or froze $561 million in grants for research into the four leading causes of death in America. At least 304 clinical trials were defunded. Additionally, 16 of the NIH's 27 institutes and centers currently lack directors, marking an unprecedented number of vacancies. Bhattacharya is known for delegating most of his responsibilities to other officials and for frequent public interviews, earning him the moniker
Related articles
Microsoft July Patch Tuesday: Update Now or Risk It
Microsoft's July Patch Tuesday delivers a record 570 security fixes, including two actively exploited zero-days. This critical update, also bringing UI improvements, is mandatory for most Windows users, with a temporary hold for specific Dell models.
The Motorola Edge 70 Max is all about power: Android — Key Details
Motorola has launched its new flagship, the Edge 70 Max, designed for power users with a massive 7100mAh silicon-carbon battery and 25W Qi2 wireless charging. It’s the first Android phone since the Pixel 10 Pro XL to support full 25W Qi2, surpassing other Qi2-enabled Androids capped at 15W. The device also offers 90W wired charging and a Snapdragon 8 Gen 5 chip.
regional: Microsoft’s reset, a new era for Seattle startups, and how
Seattle's tech sector is seeing major shifts, with Microsoft cutting 4,800 jobs and overhauling Xbox. Amidst this, the startup scene thrives, showing a surge in hardware on the GeekWire 200. AI is rapidly transforming how founders build and operate, driving efficiency and innovation across all ventures.
After Warcraft, Duncan Jones Embraces a Solo Mission with Rogue
Duncan Jones, director of *Moon* and *Warcraft*, is tackling an animated adaptation of 2000 AD's *Rogue Trooper*. Learning from his *Warcraft* experience, Jones is focused on creating a raw, standalone success, hoping to open doors for more 2000 AD films.
ICE are heavily armed killers. They’re also huge losers: DHS — Key
The Verge has published a scathing critique of ICE operations under the Trump administration, detailing a recent fatal shooting in Houston and the alleged intimidation of online critics. The article characterizes ICE as an unaccountable, heavily armed force engaging in abuses and operating as the administration's "private domestic army."
StubHub's Ethical Crossroads: A Deep Dive into Controversial Practices
StubHub's CEO, Eric Baker, is reportedly linked to funds that help finance mass scalpers on his own platform, contributing to market instability and high ticket prices. This, alongside past lawsuits for deceptive pricing, raises serious trust issues for consumers.